Sign in

CIK 0001738021 · Non-accelerated filer<br>Smaller reporting company

Compass Therapeutics, Inc.

Sign in to watch
Ticker
CMPX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-500-8099
Business address
80 GUEST STREET, BOSTON, MA, 02135
Former names
Olivia Ventures, Inc.
  1. 4 Open-market buy Chief Accounting Officer bought 20,000 shares at $0.92 ($18,400)
  2. 4 Open-market buy Chief Accounting Officer bought 2,500 shares at $1.14 ($2,850)
  3. 4/A Open-market buy Chief Accounting Officer bought 15,000 shares at $1.89 ($28,350)
  4. 4/A Open-market buy General Counsel bought 25,000 shares at $1.89 ($47,250)
  5. 4 Grant or award General Counsel acquired 25,000 shares (grant or award)
  6. 4 Grant or award Chief Accounting Officer acquired 15,000 shares (grant or award)
  7. 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 36,687 shares (to pay taxes)
  8. 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 46,777 shares (to pay taxes)
  9. 4 Grant or award CFO acquired 125,000 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 4 Grant or award CEO acquired 250,000 shares (grant or award)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award Chief Accounting Officer acquired 62,500 shares (grant or award)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Grant or award General Counsel acquired 150,000 shares (grant or award)

Page 1 of 8 · 142 filings